Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
Mirum Pharmaceuticals shares experienced a notable pullback in recent trading, sliding 5.82% to $96.24. The move comes as the stock retreats from its recent resistance level near $101.05, with selling pressure pushing it closer to the support zone at $91.43. Trading volume has picked up notably duri
Mirum Pharmaceuticals (MIRM) Stock: Down -5.82%, Support Test at $91.43 2026-05-18 - Undervalued Stocks
MIRM - Stock Analysis
3048 Comments
1870 Likes
1
Novalis
Regular Reader
2 hours ago
Remarkable effort, truly.
👍 59
Reply
2
Jyrine
Experienced Member
5 hours ago
This feels like I should remember this.
👍 210
Reply
3
Cobbie
Consistent User
1 day ago
Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
👍 272
Reply
4
Kenard
Community Member
1 day ago
Who else is here just trying to learn?
👍 234
Reply
5
Quesha
Experienced Member
2 days ago
Momentum appears intact, but minor corrections may occur.
👍 219
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.